0
     

Report Added
Report already added
Global Animal Vaccine Market, By Animal Type (Livestock, Swine, Poultry, Companion Animals, Others), By Technology (Inactive Vaccine, Live Attenuated Vaccine, Toxoid Vaccine, Recombinant Vaccine, Others), By Disease (Foot and mouth diseases, New Castle Disease, Infectious Bronchitis, Infectious Bursal Disease, Fowl pox, Rabies, Others), By Route of Administration (Subcutaneous, Intramuscular, Intraocular, Oral, Others), By Distribution Channel (Veterinary Hospitals, Veterinary Clinics, Pharmacies), By Region, Competition, Forecast & Opportunities, 2025

Global Animal Vaccine Market, By Animal Type (Livestock, Swine, Poultry, Companion Animals, Others), By Technology (Inactive Vaccine, Live Attenuated Vaccine, Toxoid Vaccine, Recombinant Vaccine, Others), By Disease (Foot and mouth diseases, New Castle Disease, Infectious Bronchitis, Infectious Bursal Disease, Fowl pox, Rabies, Others), By Route of Administration (Subcutaneous, Intramuscular, Intraocular, Oral, Others), By Distribution Channel (Veterinary Hospitals, Veterinary Clinics, Pharmacies), By Region, Competition, Forecast & Opportunities, 2025

Global animal vaccine market is forecast to grow from an estimated $ 6.3 billion in 2019 to $ 8.1 billion by 2025. Rising meat consumption is a major factor driving the market. Another factor which drives the animal vaccine market is the increasing population of companion animals, livestock, swine and others. Thus, with the increase in the population of companion animals, livestock, swine, and others, the incidence of number of diseases in animals has also increased, which is leading to the growth of the global animal vaccine market. Furthermore, prevailing pet culture has made it the responsibility of the pet owners to get their pets vaccinated and keep them healthy. The market is also gaining traction due to increasing government initiatives. Another important aspect is the rising demand for animal-derived food products, which is also positively impacting the growth of animal vaccine market.

Global animal vaccine market is segmented on the basis of animal type, technology, disease, route of administration, distribution channel, and region. Based on animal type, the market is further segmented into livestock, swine, poultry, companion animals, and others. Amongst these, livestock segment dominated the market in FY2019 as livestock is one of the fastest growing segments of animal husbandry. Based on disease, the market is further segmented into foot and mouth disease, new castle disease, infectious bronchitis, infectious bursal disease, fowl pox, rabies, and others. Amongst these, foot and mouth diseases dominated the global animal vaccine market in 2019 and is expected to dominate the market during the forecast years as well.
Major companies in the global animal vaccine market include Zoetis, Inc., Boehringer Ingelheim International GmbH, Elanco Animal Health Incorporated, Merck & Co., Inc., Ceva Sante Animale SA, Bayer AG, Virbac SA, Neogen Corporation, ImmuCell Corporation, Covetrus, Inc. and others.
Years considered for this report:
Historical Years: 2015-2018
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2021–2025
-bjective of the Study:
• To analyze and estimate the market size of the global animal vaccine market from 2015 to 2019.
• To estimate and forecast the market size of the global animal vaccine market from 2020 to 2025.
• To classify and forecast global animal vaccine market based on animal type, technology, disease, route of administration, distribution channel, and region.
• To identify dominant region or segment in the global animal vaccine market.
• To identify drivers and challenges for global animal vaccine market.
• To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global animal vaccine market.
• To conduct pricing analysis for global animal vaccine market.
• To identify and analyze the profile of leading players operating in global animal vaccine market.
• To identify key sustainable strategies adopted by market players in global animal vaccine market.
TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the country. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the country.
TechSci Research calculated the market size of global animal vaccine market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.
Key Target Audience:
• Animal vaccine manufacturers, suppliers, distributors and other stakeholders
• Government bodies such as regulating authorities and policy makers
• Organizations, forums, and alliances related to animal vaccine
• Market research and consulting firms
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.
Report Scope:
In this report, the global animal vaccine market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
• Market, By Animal Type:
- Livestock
- Swine
- Poultry
- Companion Animals
- Others
• Market, By Technology:
- Inactive Vaccine
- Live Attenuated Vaccine
- Toxoid Vaccine
- Recombinant Vaccine
- Others
• Market, By Disease:
- Foot and Mouth diseases
- New Castle Disease
- Infectious Bronchitis
- Infectious Bursal Disease
- Fowl Pox
- Rabies
- Others
• Market, By Route of Administration:
- Subcutaneous
- Intramuscular
- Intraocular
- Oral
- Others
• Market, By Distribution Channel:
- Veterinary Hospitals
- Veterinary Clinics
- Pharmacies
• Market, By Region:
- North America
United States
Canada
Mexico
- Europe
Germany
France
United Kingdom
Italy
Spain
Russia
- Asia-Pacific
China
Japan
India
South Korea
Australia
Singapore
- Middle East & Africa
South Africa
Saudi Arabia
Kuwait
UAE
- South America
Brazil
Argentina
Colombia

Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the global animal vaccine market.
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:
Company Information
• Detailed analysis and profiling of additional market players (up to five).
1. Product Overview
2. Research Methodology
3. Impact of COVID-19 on Global Animal Vaccine Market
4. Executive Summary
5. Voice of Customer
6. Global Animal Vaccine Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Animal Type (Livestock, Swine, Poultry, Companion Animals, Others)
6.2.2. By Technology (Inactive Vaccine, Live Attenuated Vaccine, Toxoid Vaccine, Recombinant Vaccine, Others)
6.2.3. By Disease (Foot and mouth diseases, New Castle Disease, Infectious Bronchitis, Infectious Bursal Disease, Fowl pox, Rabies, Others)
6.2.4. By Route of Administration (Subcutaneous, Intramuscular, Intraocular, Oral, Others)
6.2.5. By Distribution Channel (Veterinary Hospitals, Veterinary Clinics, Pharmacies)
6.2.6. By Company (2019)
6.2.7. By Region
6.3. Market Attractiveness Index
7. Asia-Pacific Animal Vaccine Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Animal Type
7.2.2. By Technology
7.2.3. By Disease
7.2.4. By Route of Administration
7.2.5. By Distribution Channel
7.2.6. By Country
7.3. Asia-Pacific: Country Analysis
7.3.1. China Animal Vaccine Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Animal Type
7.3.1.2.2. By Technology
7.3.1.2.3. By Disease
7.3.1.2.4. By Route of Administration
7.3.1.2.5. By Distribution Channel
7.3.2. India Animal Vaccine Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Animal Type
7.3.2.2.2. By Technology
7.3.2.2.3. By Disease
7.3.2.2.4. By Route of Administration
7.3.2.2.5. By Distribution Channel
7.3.3. Japan Animal Vaccine Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Animal Type
7.3.3.2.2. By Technology
7.3.3.2.3. By Disease
7.3.3.2.4. By Route of Administration
7.3.3.2.5. By Distribution Channel
7.3.4. South Korea Animal Vaccine Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Animal Type
7.3.4.2.2. By Technology
7.3.4.2.3. By Disease
7.3.4.2.4. By Route of Administration
7.3.4.2.5. By Distribution Channel
7.3.5. Australia Animal Vaccine Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Animal Type
7.3.5.2.2. By Technology
7.3.5.2.3. By Disease
7.3.5.2.4. By Route of Administration
7.3.5.2.5. By Distribution Channel
7.3.6. Singapore Animal Vaccine Market Outlook
7.3.6.1. Market Size & Forecast
7.3.6.1.1. By Value
7.3.6.2. Market Share & Forecast
7.3.6.2.1. By Animal Type
7.3.6.2.2. By Technology
7.3.6.2.3. By Disease
7.3.6.2.4. By Route of Administration
7.3.6.2.5. By Distribution Channel
8. Europe Animal Vaccine Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Animal Type
8.2.2. By Technology
8.2.3. By Disease
8.2.4. By Route of Administration
8.2.5. By Distribution Channel
8.2.6. By Country
8.3. Europe: Country Analysis
8.3.1. France Animal Vaccine Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Animal Type
8.3.1.2.2. By Technology
8.3.1.2.3. By Disease
8.3.1.2.4. By Route of Administration
8.3.1.2.5. By Distribution Channel
8.3.2. Germany Animal Vaccine Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Animal Type
8.3.2.2.2. By Technology
8.3.2.2.3. By Disease
8.3.2.2.4. By Route of Administration
8.3.2.2.5. By Distribution Channel
8.3.3. United Kingdom Animal Vaccine Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Animal Type
8.3.3.2.2. By Technology
8.3.3.2.3. By Disease
8.3.3.2.4. By Route of Administration
8.3.3.2.5. By Distribution Channel
8.3.4. Italy Animal Vaccine Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Animal Type
8.3.4.2.2. By Technology
8.3.4.2.3. By Disease
8.3.4.2.4. By Route of Administration
8.3.4.2.5. By Distribution Channel
8.3.5. Spain Animal Vaccine Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Animal Type
8.3.5.2.2. By Technology
8.3.5.2.3. By Disease
8.3.5.2.4. By Route of Administration
8.3.5.2.5. By Distribution Channel
8.3.6. Russia Animal Vaccine Market Outlook
8.3.6.1. Market Size & Forecast
8.3.6.1.1. By Value
8.3.6.2. Market Share & Forecast
8.3.6.2.1. By Animal Type
8.3.6.2.2. By Technology
8.3.6.2.3. By Disease
8.3.6.2.4. By Route of Administration
8.3.6.2.5. By Distribution Channel
9. North America Animal Vaccine Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Animal Type
9.2.2. By Technology
9.2.3. By Disease
9.2.4. By Route of Administration
9.2.5. By Distribution Channel
9.2.6. By Country
9.3. North America: Country Analysis
9.3.1. United States Animal Vaccine Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Animal Type
9.3.1.2.2. By Technology
9.3.1.2.3. By Disease
9.3.1.2.4. By Route of Administration
9.3.1.2.5. By Distribution Channel
9.3.2. Mexico Animal Vaccine Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Animal Type
9.3.2.2.2. By Technology
9.3.2.2.3. By Disease
9.3.2.2.4. By Route of Administration
9.3.2.2.5. By Distribution Channel
9.3.3. Canada Animal Vaccine Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Animal Type
9.3.3.2.2. By Technology
9.3.3.2.3. By Disease
9.3.3.2.4. By Route of Administration
9.3.3.2.5. By Distribution Channel
10. South America Animal Vaccine Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Animal Type
10.2.2. By Technology
10.2.3. By Disease
10.2.4. By Route of Administration
10.2.5. By Distribution Channel
10.2.6. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Animal Vaccine Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Animal Type
10.3.1.2.2. By Technology
10.3.1.2.3. By Disease
10.3.1.2.4. By Route of Administration
10.3.1.2.5. By Distribution Channel
10.3.2. Argentina Animal Vaccine Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Animal Type
10.3.2.2.2. By Technology
10.3.2.2.3. By Disease
10.3.2.2.4. By Route of Administration
10.3.2.2.5. By Distribution Channel
10.3.3. Colombia Animal Vaccine Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Animal Type
10.3.3.2.2. By Technology
10.3.3.2.3. By Disease
10.3.3.2.4. By Route of Administration
10.3.3.2.5. By Distribution Channel
11. Middle East and Africa Animal Vaccine Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Animal Type
11.2.2. By Technology
11.2.3. By Disease
11.2.4. By Route of Administration
11.2.5. By Distribution Channel
11.2.6. By Country
11.3. MEA: Country Analysis
11.3.1. South Africa Animal Vaccine Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Animal Type
11.3.1.2.2. By Technology
11.3.1.2.3. By Disease
11.3.1.2.4. By Route of Administration
11.3.1.2.5. By Distribution Channel
11.3.2. Saudi Arabia Animal Vaccine Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Animal Type
11.3.2.2.2. By Technology
11.3.2.2.3. By Disease
11.3.2.2.4. By Route of Administration
11.3.2.2.5. By Distribution Channel
11.3.3. UAE Animal Vaccine Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Animal Type
11.3.3.2.2. By Technology
11.3.3.2.3. By Disease
11.3.3.2.4. By Route of Administration
11.3.3.2.5. By Distribution Channel
11.3.4. Kuwait Animal Vaccine Market Outlook
11.3.4.1. Market Size & Forecast
11.3.4.1.1. By Value
11.3.4.2. Market Share & Forecast
11.3.4.2.1. By Animal Type
11.3.4.2.2. By Technology
11.3.4.2.3. By Disease
11.3.4.2.4. By Route of Administration
11.3.4.2.5. By Distribution Channel
12. Market Dynamics
12.1. Drivers
12.2. Challenges
13. Market Trends & Developments
14. Patent Analysis
15. Competitive Landscape
15.1. Zoetis, Inc.
15.2. Boehringer Ingelheim International GmbH
15.3. Elanco Animal Health Incorporated
15.4. Merck & Co., Inc.
15.5. Ceva Sante Animale SA
15.6. Bayer AG
15.7. Virbac SA
15.8. Neogen Corporation
15.9. ImmuCell Corporation
15.10. Covetrus, Inc.
16. Strategic Recommendations

Kindly Fill The Form Below

Report Title: Global Animal Vaccine Market, By Animal Type (Livestock, Swine, Poultry, Companion Animals, Others), By Technology (Inactive Vaccine, Live Attenuated Vaccine, Toxoid Vaccine, Recombinant Vaccine, Others), By Disease (Foot and mouth diseases, New Castle Disease, Infectious Bronchitis, Infectious Bursal Disease, Fowl pox, Rabies, Others), By Route of Administration (Subcutaneous, Intramuscular, Intraocular, Oral, Others), By Distribution Channel (Veterinary Hospitals, Veterinary Clinics, Pharmacies), By Region, Competition, Forecast & Opportunities, 2025


Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW